About Us

Who We Are

LimeRiver Biotechnologies Inc. is a fully integrated biosciences company dedicated to the discovery and development of therapeutic antibodies derived from natural human immunity.

Our True Human™ antibody candidates are actually derived from donors with natural human immunity. No other marketed antibody product — including "humanized" and so-called "fully human" — are actually derived from natural human immunity.

Founded on the principle that nature holds the key to the most effective treatments, LimeRiver combines cutting-edge biotechnology with the power of natural immunity to develop breakthrough therapies for some of the world's most challenging diseases.

Our state-of-the-art facilities and world-class team of scientists are dedicated to advancing our pipeline of True Human antibodies through clinical development, with programs spanning oncology, neurology, rheumatology, and infectious diseases.

LimeRiver scientist

Leadership

Meet Our Leadership Team

Our leadership team brings together decades of experience in biotechnology, research, and clinical development.

John Simard

John Simard

Founder, Chairman of the Board, Scientific Advisor

Sushma Shivaswamy

Sushma Shivaswamy

Chief Scientific Officer, Interim Chief Executive Officer

Qian Wu

Qian Wu

Senior Vice President of Clinical Operations and Analytical Quality

Norma Gonzalez

Norma Gonzalez

Vice President of Quality

Mike Cavalier

Mike Cavalier

Vice President of Manufacturing

Guiding Our Vision

Board of Directors

The Board of Directors is committed to supporting the company's strategic direction and achieving its mission. Their diverse backgrounds in science and business provide invaluable insights and governance.

John Simard

Founder, Chairman of the Board, Scientific Advisor

David Soffer

B.Sc. DMD

Tevi D. Troy

M.A., Ph.D.

Thomas Kündig

M.D.

Craig Rademaker

B.Sc.